Abstract
Amiodarone-induced keratopathy occurs against the background of systemic use of the antiarrhythmic drug amiodarone, due to deposition of iodine molecules in the lysosomes of corneal cell elements. Amiodaronic keratopathy is not a contraindication to the surgical treatment of cataract. In LLC “Tri-Z”, Moscow branch 2 patients were operated for cataracts on the background of stage 2 amiodarone keratopathy. High functional results were obtained: Visus = 0.9–1.0. Considering the possibility of progressing corneal changes with subsequent transition to the projection area of the pupil against the background of taking this drug, a consultation with a arrhythmologist was recommended in order to resolve the issue of replacing amiodarone with another antiarrhythmic drug. Key words: amiodarone; keratopathy; cataract surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
